VF
IMMX icon

Virtu Financial’s Immix Biopharma IMMX Stock Holding History

Virtu Financial’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Sell
23,847
-24,262
-50% -$225K 0.01% 831
2026
Q1 		$438K Sell
48,109
-25,682
-35% -$189K 0.02% 622
2025
Q4 		$386K Buy
+73,791
New +$304K 0.02% 724
2025
Q3 		– Sell
-17,846
Closed -$37K – 1752
2025
Q2 		$37K Buy
+17,846
New +$35.9K ﹤0.01% 1179
2022
Q2 		– Sell
-23,515
Closed -$57K – 1795
2022
Q1 		$57K Buy
+23,515
New +$87.3K ﹤0.01% 1094

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Virtu Financial's IMMX Position: Q2 2026 in Review

Virtu Financial reduced its Immix Biopharma (IMMX) stake by 50% in Q2 2026, selling an estimated $225K and leaving 23,847 shares worth $246K. The position accounts for 0.01% of the portfolio, ranked #831.

Virtu Financial first reported a position in IMMX in Q1 2022 and has held it in 5 quarters since. The position peaked at $438K in Q1 2026. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Virtu Financial held 23,847 shares of Immix Biopharma worth $246K as of Q2 2026.
  • Virtu Financial sold 24,262 Immix Biopharma shares in Q2 2026, an estimated $225K.
  • Immix Biopharma made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #831 holding.
  • Virtu Financial first reported a position in Immix Biopharma in Q1 2022 and has held it in 5 quarters since.
  • Virtu Financial's Immix Biopharma position peaked at $438K in Q1 2026.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.